SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-19-040451
Filing Date
2019-02-14
Accepted
2019-02-14 15:08:35
Documents
2
Group Members
CHRISTOPHER A. WHITECLARKE B. FUTCHHCR MOLAG FUND GP, LLCHCR MOLAG FUND, L.P.HCRP OVERFLOW FUND, L.P.HCRP OVERFLOW GP, LLCHEALTHCARE ROYALTY GP III, LLCHEALTHCARE ROYALTY MANAGEMENT, LLCMICHAEL G. CARTERPAUL J. HADDEN

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G AMENDMENT NO. 3 d706315dsc13ga.htm SC 13G/A 199968
2 EX-A d706315dex99a.htm EX-99.A 14369
  Complete submission text file 0001193125-19-040451.txt   216427
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Subject) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88402 | Film No.: 19605133
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address 300 ATLANTIC STREET SUITE 600 STAMFORD CT 06901
Business Address 300 ATLANTIC STREET SUITE 600 STAMFORD CT 06901 203.388.9080
HEALTHCARE ROYALTY PARTNERS III, L.P. (Filed by) CIK: 0001582018 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A